A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 study

Luca A. Ferri, N. Morici, Daniele Grosseto, G. Tortorella, I. Bossi, P. Sganzerla, Michele Cacucci, G. Sibilio, Stefano Tondi, A. Toso, M. Ferrario, Nicola Gandolfo, A. Ravera, M. Mariani, E. Corrada, Leonardo Di Ascenzo, A. Sonia Petronio, C. Cavallini, Nadia Moffa, Stefano De ServiStefano Savonitto

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalAmerican Heart Journal
Volume181
DOIs
Publication statusPublished - 2016

Cite this

Ferri, L. A., Morici, N., Grosseto, D., Tortorella, G., Bossi, I., Sganzerla, P., Cacucci, M., Sibilio, G., Tondi, S., Toso, A., Ferrario, M., Gandolfo, N., Ravera, A., Mariani, M., Corrada, E., Di Ascenzo, L., Petronio, A. S., Cavallini, C., Moffa, N., ... Savonitto, S. (2016). A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 study. American Heart Journal, 181, 101-106. https://doi.org/10.1016/j.ahj.2016.08.010